© 1995 by Oxford University Press
Journal of the National Cancer Institute, Vol. 87, No. 11, 827-835,
June 7, 1995
© 1995 Oxford University Press
Oral Contraceptives and Breast Cancer Risk Among Younger Women
*Environmental Epidemiology Branch, Division of Cancer Etiology, National Cancer Institute Bethesda, Md.
Fred Hutchinson Cancer Research Center Seattle, Wash
Department of Epidemiology and Biostatistics, Rollins School of Public Health, Emory University Atlanta, Ga.
Special Epidemiology Program, New Jersey State Department of Health Trenton
Division of Epidemiology, Columbia University School of Public Health New York, N.Y.
Westat, Inc. Rockville, Md.
Louise A. Brinton, Ph.D., Environmental Epidemiology Branch, National Cancer Institute, Executive Plaza North, Rm. 443, Bethesda, MD 20892.
BACKGROUND: Several studies have suggested a link between oral contraceptive use and breast cancer in younger women, but it is possible that chance or bias, including selective screening of contraceptive users, contributed to the putative association.
PURPOSE: Given that oral contraceptives were first marketed in the United States in the early 1960s, we conducted a population-based case-control study to examine the relationship between use of oral contraceptives and breast cancer among women in a recently assembled cohort, focusing on women younger than 45 years of age who had the opportunity for exposure throughout their entire reproductive years.
METHODS: Breast cancer patients and healthy control subjects were identified, the latter group by random-digit dialing, in Atlanta, Ga., Seattle/Puget Sound, Wash., and central New Jersey. In Seattle and New Jersey, the study was confined to women 20 through 44 years of age; in Atlanta the age range was extended through 54 years. Patients included women with in situ or invasive breast cancer newly diagnosed during the period of May 1, 1990, through December 31, 1992. In-person interviews were completed by 2203 (86.4%) of 2551 eligible patients and 2009 (78.1%) of 2571 eligible control subjects. Analyses focused on women younger than 45 years of age (1648 patients and 1505 control subjects) to maximize opportunities for extended exposure. Logistic regression analyses were used to obtain maximum likelihood estimates of relative risks (RRs) and their 95% confidence intervals (CIs).
RESULTS: Among women younger than 45 years, oral contraceptive use for 6 months or longer was associated with an RR for breast cancer of 13 (95% CI = 1.1–1.5). Risks were enhanced for breast cancers occurring prior to age 35 years (RR = 1.7; 95% CI = 1.2–2.6), with the RR rising to 2.2 (95% CI = 1.2–4.1) for users of 10 or more years. The RR for breast cancer for those whose oral contraceptive use began early (before age 18 years) and continued long-term (>10 years) was even higher (RR = 3.1; 95% CI = 1.4–6.7). The RRs observed for those who used oral contraceptives within 5 years of cancer diagnosis were higher than for those who had not, with the effect most marked for women younger than age 35 years (RR = 2.0; 95% CI = 13–3.1). Oral contraceptive associations were also strongest for cancers diagnosed at advanced stages. Evaluation of screening histories and methods of diagnosis failed to support the speculation that associations could be due to selective screening. Among women 45 years of age and older, no associations of risk with use of oral contraceptives were noted.
CONCLUSIONS: The relationship between oral contraceptives and breast cancer in young women appears to have a biologic basis rather than to be an artifact or the result of bias. [J Natl Cancer Inst 87:827–835, 1995]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. S. Phillips, R. C. Millikan, J. C. Schroeder, J. S. Barnholtz-Sloan, and B. J. Levine Reproductive and Hormonal Risk Factors for Ductal Carcinoma In situ of the Breast Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1507 - 1514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Dolle, J. R. Daling, E. White, L. A. Brinton, D. R. Doody, P. L. Porter, and K. E. Malone Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years Cancer Epidemiol. Biomarkers Prev., April 1, 2009; 18(4): 1157 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Reding, J. R. Daling, D. R. Doody, C. A. O'Brien, P. L. Porter, and K. E. Malone Effect of Prediagnostic Alcohol Consumption on Survival after Breast Cancer in Young Women Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 1988 - 1996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Britt, A. Ashworth, and M. Smalley Pregnancy and the risk of breast cancer Endocr. Relat. Cancer, December 1, 2007; 14(4): 907 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B. Nichols, A. Trentham-Dietz, K. M. Egan, L. Titus-Ernstoff, J. M. Hampton, and P. A. Newcomb Oral Contraceptive Use and Risk of Breast Carcinoma In situ Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2262 - 2268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. E. Hahn, M. L. Bondy, M. Selvan, M. J. Lund, J. M. Liff, E. W. Flagg, L. A. Brinton, P. Porter, J. W. Eley, and R. J. Coates Factors Associated with Advanced Disease Stage at Diagnosis in a Population-based Study of Patients with Newly Diagnosed Breast Cancer Am. J. Epidemiol., November 1, 2007; 166(9): 1035 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. F. Trivers, M. D. Gammon, P. E. Abrahamson, M. J. Lund, E. W. Flagg, P. G. Moorman, J. S. Kaufman, J. Cai, P. L. Porter, L. A. Brinton, et al. Oral Contraceptives and Survival in Breast Cancer Patients Aged 20 to 54 Years Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1822 - 1827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sanderson, J. R. Daling, D. R. Doody, and K. E. Malone Perinatal factors and mortality from breast cancer. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1984 - 1987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kahlenborn, F. Modugno, D. M. Potter, and W. B. Severs Oral Contraceptive Use as a Risk Factor for Premenopausal Breast Cancer: A Meta-analysis Mayo Clin. Proc., October 1, 2006; 81(10): 1290 - 1302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Cantwell, A. E. Millen, R. Carroll, B. L. Mittl, S. Hermansen, L. A. Brinton, and N. Potischman A Debriefing Session with a Nutritionist Can Improve Dietary Assessment Using Food Diaries J. Nutr., February 1, 2006; 136(2): 440 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Suter, K. E. Malone, J. R. Daling, D. R. Doody, and E. A. Ostrander Androgen Receptor (CAG)n and (GGC)n Polymorphisms and Breast Cancer Risk in a Population-Based Case-Control Study of Young Women Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 127 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Althuis, L. A. Brinton, E. C.G. Grant, B. Friedenson, P. A. Marchbanks, J. A. McDonald, and H. G. Wilson Oral Contraceptives and the Risk of Breast Cancer N. Engl. J. Med., October 31, 2002; 347(18): 1448 - 1449. [Full Text] [PDF]
|
|
|
|
|
|
M. B. Terry, M. D. Gammon, J. B. Schoenberg, L. A. Brinton, N. Arber, and H. Hibshoosh Oral Contraceptive Use and Cyclin D1 Overexpression in Breast Cancer among Young Women Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1100 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Britton, M. D. Gammon, J. B. Schoenberg, J. L. Stanford, R. J. Coates, C. A. Swanson, N. Potischman, K. E. Malone, D. J. Brogan, J. R. Daling, et al. Risk of Breast Cancer Classified by Joint Estrogen Receptor and Progesterone Receptor Status among Women 20-44 Years of Age Am. J. Epidemiol., September 15, 2002; 156(6): 507 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Thomas, R. A. Carter, W. H. Bush Jr., R. M. Ray, J. L. Stanford, C. D. Lehman, J. R. Daling, K. Malone, and S. Davis Risk of Subsequent Breast Cancer in Relation to Characteristics of Screening Mammograms from Women Less Than 50 Years of Age Cancer Epidemiol. Biomarkers Prev., June 1, 2002; 11(6): 565 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Daling, K. E. Malone, D. R. Doody, B. O. Anderson, and P. L. Porter The Relation of Reproductive Factors to Mortality from Breast Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2002; 11(3): 235 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Brogan, M. M. Denniston, J. M. Liff, E. W. Flagg, R. J. Coates, and L. A. Brinton Comparison of Telephone Sampling and Area Sampling: Response Rates and Within-Household Coverage Am. J. Epidemiol., June 1, 2001; 153(11): 1119 - 1127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Grabrick, L. C. Hartmann, J. R. Cerhan, R. A. Vierkant, T. M. Therneau, C. M. Vachon, J. E. Olson, F. J. Couch, K. E. Anderson, V. S. Pankratz, et al. Risk of Breast Cancer With Oral Contraceptive Use in Women With a Family History of Breast Cancer JAMA, October 11, 2000; 284(14): 1791 - 1798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M P. Madigan, R. Troisi, N. Potischman, D. Brogan, M. D Gammon, K. E Malone, and L. A Brinton Characteristics of respondents and non-respondents from a case-control study of breast cancer in younger women Int. J. Epidemiol., October 1, 2000; 29(5): 793 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. I. Graubard and E. L. Korn Analyzing Health Surveys for Cancer-Related Objectives J Natl Cancer Inst, June 16, 1999; 91(12): 1005 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Gammon, H. Hibshoosh, M. B. Terry, S. Bose, J. B. Schoenberg, L. A. Brinton, J. L. Bernstein, and W. D. Thompson Oral Contraceptive Use and Other Risk Factors in Relation to HER-2/neu Overexpression in Breast Cancer Among Young Women Cancer Epidemiol. Biomarkers Prev., May 1, 1999; 8(5): 413 - 419. [Abstract] [Full Text]
|
|
|
|
|
|
M. D. Gammon, H. Hibshoosh, M. B. Terry, S. Bose, J. B. Schoenberg, L. A. Brinton, J. L. Bernstein, and W. D. Thompson Cigarette Smoking and Other Risk Factors in Relation to p53 Expression in Breast Cancer among Young Women Cancer Epidemiol. Biomarkers Prev., March 1, 1999; 8(3): 255 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Malone, J. R. Daling, J. D. Thompson, C. A. O'Brien, L. V. Francisco, and E. A. Ostrander BRCA1 Mutations and Breast Cancer in the General Population: Analyses in Women Before Age 35 Years and in Women Before Age 45 Years With First-Degree Family History JAMA, March 25, 1998; 279(12): 922 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Cook, J. R. Daling, L. F. Voigt, M. P. deHart, K. E. Malone, J. L. Stanford, N. S. Weiss, L. A. Brinton, M. D. Gammon, and D. Brogan Characteristics of Women With and Without Breast Augmentation JAMA, May 28, 1997; 277(20): 1612 - 1617. [Abstract] [PDF]
|
|
|
|
|
|
J. P. Struewing, P. Hartge, S. Wacholder, S. M. Baker, M. Berlin, M. McAdams, M. M. Timmerman, L. C. Brody, and M. A. Tucker The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews N. Engl. J. Med., May 15, 1997; 336(20): 1401 - 1408. [Abstract] [Full Text] [PDF]
|
|